πŸ‡ΊπŸ‡Έ FDA
Patent

US 6355619

Peptide tumor cell growth inhibitors

expired A61KA61K38/08A61P

Quick answer

US patent 6355619 (Peptide tumor cell growth inhibitors) held by The Board of Regents of the University of Texas System expires Mon Mar 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
45
CPC classes
A61K, A61K38/08, A61P, A61P35/00